Adipogenic, chondrogenic and osteogenic differentiation of clonally derived human dermal fibroblasts.
The apparent need of an autologous cell source for tissue engineering applications has led researchers to explore the presence of cells with stem cell plasticity in several human tissues. Dermal fibroblasts (FBs) are easy to harvest, expand in vitro and store, rendering them plausible candidates for cell-based therapies. The aim of the present study was to observe the effects of adipogenic, chondrogenic and osteogenic induction media on the phenotype of human FBs. Human preadipocytes obtained from fat tissue have been proposed as an adult stem cell source with suitable characteristics, and were used as control cells in regard to their differentiation potential. Routine staining, immunohistochemical analysis and alkaline phosphatase assay were employed, in order to study the phenotypic shift. FBs were shown to possess multilineage potential, giving rise to fat-, cartilage- and bone-like cells. To exclude contaminant progenitor cells or cell fusion giving rise to tissue with adipocyte-, chondrocyte- and osteoblast-like cells, single-cell cloning was performed. Single-cell-cloned FBs (sccFBs) displayed a similar differentiation potential as primary-culture FBs. The presence of 'stem-cell-specific' surface antigens was analyzed using flow cytometry. The results reveal that sccFBs have several of the markers associated with cells exhibiting stem cell plasticity. The findings presented here are corroborated by the findings of other groups, and suggest the use of human dermal FBs in cell-based therapies for the reconstruction of fat, cartilage and bone.
Junker
Johan P E
JP
Laboratory for Reconstructive Plastic Surgery, Department of Plastic and Hand Surgery, and Department of Clinical and Experimental Medicine, University Hospital, Linköping, Sweden. johan.junker@ibk.liu.se
Sommar
Pehr
P
Skog
Mårten
M
Johnson
Hans
H
Kratz
Gunnar
G
D017667:Adipocytes / Q000166:cytology*; D050156:Adipogenesis / Q000502:physiology*; D053687:Adult Stem Cells; D053674:Aggrecans / Q000096:biosynthesis; D002352:Carrier Proteins; D002454:Cell Differentiation; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology*; D002999:Clone Cells; D024043:Collagen Type II / Q000096:biosynthesis; D020405:Dermis / Q000166:cytology*; D005347:Fibroblasts / Q000166:cytology*; D006801:Humans; D015675:Osteocalcin / Q000096:biosynthesis; D010012:Osteogenesis / Q000502:physiology*; D015676:Osteonectin / Q000096:biosynthesis; D000070778:Perilipin-1; D010750:Phosphoproteins / Q000096:biosynthesis; D013234:Stem Cells / Q000166:cytology
C508319:ACAN protein, human; D053674:Aggrecans; D002352:Carrier Proteins; D024043:Collagen Type II; D015676:Osteonectin; D000070778:Perilipin-1; D010750:Phosphoproteins; D015675:Osteocalcin